Amarin | AMRN - Capitalisation Boursière





Capitalisation Boursière Changement Date
AbbVie USD 384.69B 19.14B 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
AstraZeneca USD 301.25B 13.1B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
DBV Technologies USD 629M 601M 2026-07
Esperion Therapeutics USD 885M 351M 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Halozyme Therapeutics USD 7.66B 257M 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Nektar Therapeutics USD 12.82B 11.96B 2026-07
Neurocrine Biosciences USD 13.25B 890M 2026-03
Novartis USD 307.76B 15.54B 2026-03